On July 14, 2025, a new whitepaper sponsored by the Association for Accessible Medicines was released. “The Long-Term Effects of Medicare Price Negotiations on Drug Competition” was written by Alex Brill and Christy Robinson at Matrix Global Advisors. It examines the potential long-term impact that the federal government’s role as a price setter could have … Continue reading A Conversation with Alex M. Brill, CEO, Matrix Global Advisors